← Back to headlines
Annovis Bio Regains NYSE Listing Compliance
Annovis Bio, a clinical-stage pharmaceutical company, has successfully regained compliance with the New York Stock Exchange's listing requirements.
26 May, 12:22 — 26 May, 12:22
Sources
Showing 1 of 1 sources
Related Stories
Construction Begins on Challenging New Highway Linking Skopje to Kosovo
20m ago
SolarEdge Stock Surges After UBS Upgrade Citing Inverter Import Ban
35m ago
RedBird Capital Advances Talks to Acquire Stake in Puck Media
37m ago
Meta Agrees to $18 Billion Settlement Over Alleged Social Media Harm to Children
41m ago